Published in Cancer Weekly, July 13th, 1998
Genetronics is utilizing the long-established research technology called electroporation to more efficiently and effectively deliver life-saving drugs or beneficial genes directly into the human cell, Lois Crandell, Genetronics, told participants of the Cruttenden Roth Healthcare Conference in New York.
Dr. William Panje, a Chicago surgeon, used electroporation on ten patients in a Phase I/II clinical trial with late-stage head and neck cancer patients who had failed conventional therapies. Five...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-07-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.